Gallant Revenue and Competitors
Estimated Revenue & Valuation
- Gallant's estimated annual revenue is currently $1.8M per year.
- Gallant's estimated revenue per employee is $77,500
- Gallant's total funding is $11M.
Employee Data
- Gallant has 23 Employees.
- Gallant grew their employee count by 15% last year.
Gallant Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $32.9M | 230 | 8% | $5M | N/A |
#2 | $1.8M | 23 | 15% | $11M | N/A |
#3 | $16M | 71 | 51% | N/A | N/A |
#4 | $2791.7M | 8139 | 3% | N/A | N/A |
What Is Gallant?
Gallant is a new and unique regenerative medicine business focusing on helping pets have better, higher-quality lives. Partnering with veterinarians and pet parents, Gallant has the ability to collect and bank young stem cells from the reproductive tissue which would otherwise be discarded during a spay/neuter. These young, potent stem cells are stored for the future when distinct therapies are needed. Gallant opens a new world of wellness opportunity and makes proven regenerative medicine accessible to pets, pet parents and veterinarians.
keywords:N/A
$11M
Total Funding
23
Number of Employees
$1.8M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gallant News
Canada's Jocelyn Peterman and Brett Gallant were knocked out of the world mixed doubles curling championship in Geneva on Friday after...
Brett Gallant and Jocelyn Peterman compete at the World Mixed Doubles Curling Championship 2022, Geneva, Switzerland on Friday, April 29, 2022.
Brett Gallant and Jocelyn Peterman represented Canada at the 2022 world mixed doubles curling championship in Geneva, Switzerland. STORY...
With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based startup Gallant is now opening its doors for the first time. The company was founded by DogVacay founder and chief executive Aaron Hirschhorn after seeing hi ...
Gallant, a Los Angeles, CA-based animal biotech company, raised $11m in funding. Backers included Maveron, Bold Capital Partners, Bling Capital, Science Inc. and more. The company is using the funds for research and development, clinical studies to advance treatments and education campaigns on ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 23 | -8% | N/A |
#2 | $3.4M | 23 | 21% | N/A |
#3 | $2.3M | 23 | N/A | N/A |
#4 | $4M | 23 | -21% | $74.4M |
#5 | $2.4M | 23 | 5% | N/A |